lilly sars-cov-2 neutralizing antibody program update
TRANSCRIPT
S A R S - C o V - 2 N E U T R A L I Z I N G A N T I B O D Y P R O G R A M U P D A T E
O C T O B E R 7 , 2 0 2 0
▪
▪
▪
▪
▪
Not for promotional use 6
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪ ≤
▪
▪ ±
▪
8
≥
≥
> >
*Urinary tract infection requiring hospitalization, deemed unrelated to study drug
▪
▪
▪
≥
▪
▪
−
−
− <
<
▪
▪
▪
≥ @
≥
≥ ≥
−
−
−
−
−
▪
▪
▪
–
–
–
– <
▪
–
–
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪